Comparison of sodium excreting effect between furosemide and indapamide combination with furosemide and metolazone combination in congestive heart failure patients
Not Applicable
- Conditions
- Congestive Heart Failure
- Registration Number
- SLCTR/2017/041
- Lead Sponsor
- Rehman Medical Institute
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow up complete
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
New York Hear Association Grade –III
New York Hear Association Grade - IV
Adults from 18years to 90years of both genders will be included
Exclusion Criteria
Chronic Kidney Disease - Ultrasonographic evidence of chronic kidney disease
Chronic Liver Disease - Ultrasonographic evidence of liver fibrosis
Malnutrition- serum albumin concentration of less than 3g/dl
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method urinary sodium level in a spot urine sample [ day 1, day 3 and day 5]<br>
- Secondary Outcome Measures
Name Time Method Measurement of 24 hour urine output and daily weight in kg [ day 1, day 3 and day 5]<br>